Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
St. John's wort in Generalized Social Anxiety Disorder
NCT00118833Phase 3Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized social anxiety disorder (GSAD) comparing St. John's wort with Placebo (2 arms). Primary endpoint: Clinical Global Impression at 10 weeks. Started Aug 2002; status: completed.
02
Drugs
hypericum perforatum
03
Conditions
generalized social anxiety disorder (GSAD)
Beyond the preview
Go deeper on NCT00118833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118833.